222 related articles for article (PubMed ID: 12715327)
21. Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern.
Dargent JL; Lespagnard L; Sirtaine N; Cantinieaux B; Li R; Hermans P
APMIS; 2007 Jul; 115(7):869-74. PubMed ID: 17614857
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
[TBL] [Abstract][Full Text] [Related]
23. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection.
Ogata M; Imamura T; Mizunoe S; Ohtsuka E; Kikuchi H; Nasu M
Am J Hematol; 2003 Jun; 73(2):126-30. PubMed ID: 12749015
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
26. Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorder.
Yates JA; Zakai NA; Griffith RC; Wing EJ; Schiffman FJ
AIDS Read; 2007 Dec; 17(12):596-8, 601. PubMed ID: 18178978
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
28. Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.
Engels EA; Mbulaiteye SM; Othieno E; Gomez M; Mathew S; Cesarman E; Knowles DM; Chadburn A
Hum Pathol; 2007 Feb; 38(2):308-14. PubMed ID: 17097130
[TBL] [Abstract][Full Text] [Related]
29. [Detection of Epstein-Barr virus in T cell lymphoma and clinicopathologic analysis].
He ZG; Huang YP; Guo XC; Lin DM; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):229-33. PubMed ID: 15340564
[TBL] [Abstract][Full Text] [Related]
30. A unique presentation of an Epstein-Barr virus-associated natural killer/T-cell lymphoproliferative disorder in a white male adolescent.
Summers E; Samadashwily G; Florell SR
Arch Dermatol; 2011 Feb; 147(2):216-20. PubMed ID: 21339449
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
32. Reflections on Epstein-Barr virus: some recently resolved old uncertainties.
Epstein MA
J Infect; 2001 Aug; 43(2):111-5. PubMed ID: 11676516
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
[TBL] [Abstract][Full Text] [Related]
34. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
35. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
36. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan.
Hirose Y; Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawabata H; Fukushima T; Ogawa N; Wano Y; Umehara H
Eur J Haematol; 2006 Feb; 76(2):109-18. PubMed ID: 16405431
[TBL] [Abstract][Full Text] [Related]
37. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
Bestawros A; Boulassel MR; Michel RP; Routy JP
J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
[No Abstract] [Full Text] [Related]
38. Initial human herpesvirus-8 rash and multicentric Castleman disease.
Wyplosz B; Carlotti A; Escaut L; Vignier N; Guettier C; Agbalika F; Vittecoq D; Dupin N
Clin Infect Dis; 2008 Sep; 47(5):684-8. PubMed ID: 18652555
[TBL] [Abstract][Full Text] [Related]
39. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
40. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]